[ad_1]
US and International VC funds abandoned Canadian market in Q2, 2022
Canadian VC disbursements reached $1.17 billion in Q2, down 67% from Q1 2022 and 76% from Q2 2021
- 299 financings for $4.72 billion for the first half of 2022. 127 venture capital financings for disbursements of $1.17 billion in Q2 2022.
- Investors from US and foreign countries/regions invested $3.31 billion accounting 70% of the total disbursement, down from 74% recorded in Q1 2022. US investors invested $2.62 billion or 55% of the total.
- Cleantech companies received $603 millionthird behind $2.78 billion by ICT companies and $634 million by financial companies.
- Biotech companies raised $464 millioncontinuing to lag at fourth place down from its usual second place.
- US VCs and foreign corporate VCs continue to lead all investor types with $1.69 billion and $574 million investments respectively. Canadian VCs ranked 3rd investing $410 million.
- $1.72 billion raised by 21 Canadian venture funds.
All dollar ($) figures in Canadian dollar unless otherwise noted.
TORONTO, Aug. 18, 2022 /CNW/ – Canadian companies secured $1.17 billion in venture capital funding1 through 127 financings in Q2 2022, down 67% from the amount raised in Q1 2022 and 76% from the amount raised in Q2 2021.
For the first half of 2022, Canadian VC disbursements reached $4.72 billion from 299 financings, down 40% from total disbursements in first half 2021.
NVCA/PitchBook reported Q2 2022 US activities showed an decrease of 24% from Q1 2022 and 23% from Q2 2021, an decrease of 9% for the first half compared to first half of 2021.
|
______________________ |
|
1 CPE Canadian VC investment data includes only primary funding by companies and excludes secondary transactions involving investors buying shares from founders or existing investors with no money flowing into companies. US $300 million secondary transaction as part of 1Password’s US $620M Series C transaction was excluded, so were some known PE transactions (Hydrostor), VC deals by foreign HQ companies with Canadian subsidiaries (Domain Therapeutics, Shoplazza, Ventus, Faire Wholesale.). CPE data is based on closing date not the announcement date for accurate tracking of Canadian VC investment activities . |
